Cathie Wood acquired 18.2 Thousand Regeneron Pharmaceuticals shares worth $17.7 Million. That's 0.14% of their equity portfolio (79th largest holding). The first Regeneron Pharmaceuticals trade was made in Q4 2016. Since then Cathie Wood bought shares nine more times and sold shares on sixteen occasions. The stake costed the investor $9.22 Million, netting the investor a gain of 92% so far.
Gene editing stocks are among the most intriguing in the biotech scene. The genomics revolution may be as exciting as the ongoing artificial intelligence one...
InvestorPlace, 9 days agoRelated Stocks: AMAT , REGN , FDX , SHW , MIME , BCYC , FITB , OGN , TRV , ALL , GLW , MTB0 , AZPN , DG ,
GuruFocus, over 2 years ago